In order to evaluate the effect of total parenteral nutrition associated with glutamine and enteral fluid therapy, associated or not with glutamine, on the lipidogram of horses subjected to starvation ...
17d
CorMedix Touts Q2 REZZAYO Data, Melinta Integration and DefenCath Reimbursement Shift at Conference
CorMedix (NASDAQ:CRMD) executives used a presentation at the Citizens Life Sciences Conference to outline the company’s focus ...
Cost basis is the original purchase price of an asset. Tracking cost basis is key to tax-efficient investing. Many, or all, of the products featured on this page are from our advertising partners who ...
CorMedix (NASDAQ:CRMD) executives said 2025 was a “transformational” year, highlighted by DefenCath reaching peak sales of ...
(Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced financial results for the ...
Abstract: This research explores the challenges of an aging society, where the elderly population is on the rise in many countries, including Thailand. Technological products and services are crucial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results